Log In
Print this Print this

Biophage-PR (AB-PA01, AmpliPhage-001)

  Manage Alerts
Collapse Summary General Information
Company AmpliPhi Biosciences Corp.
DescriptionLytic bacteriophages against Pseudomonas aeruginosa
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today